12/7/2022 | BKCVIG | S&P upgrades Boston Scientific
|
12/6/2022 | BKCVIG | Fitch boosts Boston Scientific
|
3/3/2022 | BKCVIG | Moody's gives American Medical notes Baa1
|
3/3/2022 | BKCVIG | S&P assigns American Medical notes BBB
|
3/3/2022 | BKCVIG | Fitch gives American Medical notes BBB
|
3/2/2022 | BKCVIG | S&P turns Boston Scientific view to positive
|
2/23/2022 | BKCVIG | Moody's boosts Boston Scientific
|
12/6/2021 | BKCVIG | Fitch turns Boston Scientific view to positive
|
5/27/2021 | BKCVIG | S&P boosts Boston Scientific
|
5/27/2020 | CV | Boston Scientific greenshoe exercised in full, ups convertible preferreds to $1.01 billion
|
5/22/2020 | CV | Market Commentary: Boston Scientific, Under Armour, Five9 expand on debut; Penn Gaming skyrockets
|
5/22/2020 | CV | Market Commentary: Morning Commentary: Boston Scientific, Under Armour, Five9 make their aftermarket debuts
|
5/22/2020 | CV | New Issue: Boston Scientific prices $875 million convertible preferreds to yield 5.5%, up 22.5%
|
5/21/2020 | CV | Market Commentary: Boston Scientific, Under Armour, Five9 eyed; Becton Dickinson, Cryoport trade higher
|
5/21/2020 | CV | Market Commentary: Morning Commentary: Boston Scientific, Under Armour, Five9 eyed; Becton Dickinson active
|
5/20/2020 | CV | Market Commentary: Boston Scientific on tap; Cryoport, Becton Dickinson in focus; new deals trade higher
|
5/20/2020 | CV | Boston Scientific talks $750 million convertible preferreds at 5.25%-5.75%, up 17.5%-22.5%
|
10/19/2007 | CV | Market Commentary: Gilead falls after positive earnings; Medtronic drags down St. Jude; AMD weighs down Intel; Yahoo! gives back
|
9/7/2006 | CV | Credit Suisse to sell 8.5% reverse convertibles linked to Boston Scientific
|
4/17/2006 | BTCV | New Issue: Lehman prices $100.4 million 7.5% Yeelds linked to Boston Scientific
|
3/22/2006 | BTCV | Boston Scientific files automatic shelf
|
9/6/2005 | BTCV | New Issue: Goldman Sachs prices $15 million 1.2% notes mandatorily exchangeable for Boston Scientific
|
7/6/2005 | BTCV | New Issue: ABN Amro sells $575,000 8.25% reverse exchangeables linked to Boston Scientific
|
7/5/2005 | BTCV | S&P: Verdict supports Boston Scientific
|
3/23/2005 | CV | New Issue: Barclays sells $1.5 million 8.50% exchangeables linked to Boston Scientific
|
3/9/2005 | CV | New Issue: ABN Amro sells $725,000 9.25% reverse exchangeables linked to Boston Scientific
|
11/24/2004 | CV | New Issue: ABN Amro sells $4.9 million 9% reverse exchangeables linked to Boston Scientific
|